Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-Wide Gene Expression Profiling Defines the Mechanism of Anticancer Effect of Colorectal Cancer Cell-Derived Conditioned Medium on Acute Myeloid Leukemia. | Genes (Basel) | 2022 | 35627268 | PubTator, text mining | PubMed |
| Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment. | Cancers (Basel) | 2022 | 35626170 | PubTator, text mining | PubMed |
| The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19. | Mediterr J Hematol Infect Dis | 2022 | 35615323 | PubTator, text mining | PubMed |
| Comparison of Gene Expression Profiles of Signet Ring Cell Carcinoma and Poorly Cohesive Carcinoma in Early Gastric Cancer. | Clin Med Insights Oncol | 2022 | 35603092 | PubTator, text mining | PubMed |
| Reticular Skin Rash as an Adverse Effect of 5-Azacitidine. | Cureus | 2022 | 35602804 | PubTator, text mining | PubMed |
| The TRiCky Business of Protein Folding in Health and Disease. | Front Cell Dev Biol | 2022 | 35602608 | PubTator, text mining | PubMed |
| Hydrophilic Realgar Nanocrystals Prolong the Survival of Refractory Acute Myeloid Leukemia Mice Through Inducing Multi-Lineage Differentiation and Apoptosis. | Int J Nanomedicine | 2022 | 35599749 | PubTator, text mining | PubMed |
| PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia. | Leukemia | 2022 | 35590033 | PubTator, text mining | PubMed |
| Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells. | Exp Hematol Oncol | 2022 | 35581670 | PubTator, text mining | PubMed |
| Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies. | Cancer Sci | 2022 | 35579198 | PubTator, text mining | PubMed |
| Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation. | Oncotarget | 2022 | 35574218 | PubTator, text mining | PubMed |
| Synergistic efficacy of homoharringtonine and venetoclax on acute myeloid leukemia cells and the underlying mechanisms. | Ann Transl Med | 2022 | 35571387 | PubTator, text mining | PubMed |
| Dissecting the Genetic and Non-Genetic Heterogeneity of Acute Myeloid Leukemia Using Next-Generation Sequencing and In Vivo Models. | Cancers (Basel) | 2022 | 35565315 | PubTator, text mining | PubMed |
| Optical Genome Mapping as a Diagnostic Tool in Pediatric Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | 35565187 | PubTator, text mining | PubMed |
| Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling. | Int J Mol Sci | 2022 | 35563538 | PubTator, text mining | PubMed |
| Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia. | Int J Mol Sci | 2022 | 35563085 | PubTator, text mining | PubMed |
| Ripk3 signaling regulates HSCs during stress and represses radiation-induced leukemia in mice. | Stem Cell Reports | 2022 | 35561683 | PubTator, text mining | PubMed |
| Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc. | Haematologica | 2022 | 35546301 | PubTator, text mining | PubMed |
| Tracing the origins of glioblastoma by investigating the role of gliogenic and related neurogenic genes/signaling pathways in GBM development: a systematic review. | World J Surg Oncol | 2022 | 35538578 | PubTator, text mining | PubMed |
| Case Report: Unusual Varicella-Zoster Virus Meningoencephalitis With Meningomyelitis Mimicking Central Nervous System Leukemia. | Front Med (Lausanne) | 2022 | 35530048 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=37